Mansoor Saleh

2024

Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies

Saleh, M., Barve, M., Subbiah, V., Papadopoulos, K. P., Morgensztern, D., Mettu, N. B., Roychowdhury, S., Spanggaard, I., Veronese, M. L., Tian, C., Silverman, I. M. & Gutierrez, M., Jul 2024, In: ESMO Open. 9, 7, 103625.

Research output: Contribution to journal › Article › peer-review

Open Access

Regulatory approval of clinical trials: is it time to reinvent the wheel?

Saleh, M., Sharma, K., Shamshudin, A., Obayo, I., Gondi, S. & Karimi, N., 24 Jan 2024, In: BMJ Global Health. 9, 1, e013727.

Research output: Contribution to journal › Article › peer-review

Open Access

2023

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

Nadal, E., Saleh, M., Aix, S. P., Ochoa-de-Olza, M., Patel, S. P., Antonia, S., Zhao, Y., Gueorguieva, I., Man, M., Estrem, S. T., Liu, J., Avsar, E., Lin, W. H., Benhadji, K. A., Gandhi, L., Guba, S. C. & Diaz, I. A., Dec 2023, In: BMC Cancer. 23, 1, 708.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Citations (Scopus)

Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients

Elkholy, A., Avuthu, N., Abdalla, M., Behring, M., Bajpai, P., Kim, H. G., Header, D., Abo Elwafa, R. AH., Saed, H., Embaby, A., El-Nikhely, N., Obuya, S., Mohamed, M., Badawy, A. A., Nawar, A., Afaq, F., Rogers, L. Q., Bae, S., Shikany, J. M., Bateman, L. B., & 7 othersFouad, M., Saleh, M., Samuel, T., Varambally, S., Guda, C., Arafat, W. & Manne, U., Jul 2023, In: Heliyon. 9, 7, e18035.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Citation (Scopus)

Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics

Sayed, S., Koka, H., Abubakar, M., Gardner, K., Salgado, R., Moloo, Z., Caban-Ureña, A. B., Rosen, D., Castro, P., Saleh, M., Shaikh, A. J., Shah, J., Figueroa, J., Makokha, F., Ha, H. K., Wang, Z., Magangane, P., Naidoo, R., Ngundo, V., Yang, X. R., & 1 othersGovender, D., Jun 2023, In: Breast Cancer Research and Treatment. 199, 2, p. 401-413 13 p.

Research output: Contribution to journal › Article › peer-review

2022

A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa

Saleh, M., Sharma, K., Shah, J., Karsan, F., Waweru, A., Musumbi, M., Shah, R., Sayed, S., Abayo, I., Karimi, N., Gondi, S., Rupani, S., Kirathe, G. & Amariati, H., Jul 2022, In: PLoS ONE. 17, 7 July, e0270594.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Citations (Scopus)

Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa

Waljee, A. K., Weinheimer-Haus, E. M., Abubakar, A., Ngugi, A. K., Siwo, G. H., Kwakye, G., Singal, A. G., Rao, A., Saini, S. D., Read, A. J., Baker, J. A., Balis, U., Opio, C. K., Zhu, J. & Saleh, M. N., Jul 2022, In: Gut. 71, 7, p. 1259-1265 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

22 Citations (Scopus)

A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients

Obuya, S., Elkholy, A., Avuthu, N., Behring, M., Bajpai, P., Agarwal, S., Kim, H. G., El-Nikhely, N., Akinyi, P., Orwa, J., Afaq, F., Abdalla, M., Michael, A., Farouk, M., Bateman, L. B., Fouad, M., Saleh, M., Guda, C., Manne, U. & Arafat, W., Oct 2022, In: Journal of Gastrointestinal Oncology. 13, 5, p. 2282-2292 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Citations (Scopus)

Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: A behavioral risk factor surveillance system study

Jain, V., Rifai, M. A., Brinzevich, D., Taj, M., Saleh, M., Krittanawong, C., Patel, J., Patel, A., Lee, M. T., Mahtta, D. & Virani, S. S., 1 Feb 2022, In: European Journal of Preventive Cardiology. 29, 3, p. 493-501 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Citations (Scopus)

Demographic, Clinical, and Co-Morbidity Characteristics of COVID-19 Patients: A Retrospective Cohort from a Tertiary Hospital in Kenya

Shah, R., Shah, J., Kunyiha, N., Ali, S. K., Sayed, S., Surani, S. & Saleh, M., 2022, In: International Journal of General Medicine. 15, p. 4237-4246 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Citations (Scopus)

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

Subbiah, V., Iannotti, N. O., Gutierrez, M., Smith, D. C., Féliz, L., Lihou, C. F., Tian, C., Silverman, I. M., Ji, T. & Saleh, M., May 2022, In: Annals of Oncology. 33, 5, p. 522-533 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

113 Citations (Scopus)

Promoting Best Practice in Cancer Care in Sub Saharan Africa

Sharma, K., Sayed, S. & Saleh, M., 6 Jul 2022, In: Frontiers in Medicine. 9, 950309.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Citations (Scopus)

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study

Zucali, P. A., Lin, C. C., Carthon, B. C., Bauer, T. M., Tucci, M., Italiano, A., Iacovelli, R., Su, W. C., Massard, C., Saleh, M., Daniele, G., Greystoke, A., Gutierrez, M., Pant, S., Shen, Y. C., Perrino, M., Meng, R., Abbadessa, G., Lee, H., Dong, Y., & 5 othersChiron, M., Wang, R., Loumagne, L., Lépine, L. & De Bono, J., 20 Jan 2022, In: Journal for ImmunoTherapy of Cancer. 10, 1, e003697.

Research output: Contribution to journal › Article › peer-review

Open Access

30 Citations (Scopus)

2021

Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya

Sayed, S., Fan, S., Moloo, Z., Wasike, R., Bird, P., Saleh, M., Shaikh, A. J., Figueroa, J. D., Naidoo, R., Makokha, F. W., Gardner, K., Oigara, R., Njoroge, F. W., Magangane, P., Mutebi, M., Chauhan, R., Mwanzi, S., Govender, D. & Yang, X. R., Dec 2021, In: Breast Cancer Research. 23, 1, 68.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Citations (Scopus)

Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women

Saleh, M., Chandrashekar, D. S., Shahin, S., Agarwal, S., Kim, H. G., Behring, M., Shaikh, A. J., Moloo, Z., Eltoum, I. E. A., Yates, C., Varambally, S. & Manne, U., Jul 2021, In: Translational Oncology. 14, 7, 101086.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Citations (Scopus)

Phase 1 trial of ALRN-6924, a dual inhibitor of MDMX and MDM2, in patients with solid tumors and lymphomas bearing wild-type TP53

Saleh, M. N., Patel, M. R., Bauer, T. M., Goel, S., Falchook, G. S., Shapiro, G. I., Chung, K. Y., Infante, J. R., Conry, R. M., Rabinowits, G., Hong, D. S., Wang, J. S., Steidl, U., Naik, G., Guerlavais, V., Vukovic, V., Allen Annis, D., Aivado, M. & Meric-Bernstam, F., 1 Oct 2021, In: Clinical Cancer Research. 27, 19, p. 5236-5247 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

87 Citations (Scopus)

2020

Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy clinicians

Saleh, M., Naik, G., Jester, P., Joiner, C., Westfall, E., Kimberlin, D. W., Willig, J., Redden, D., Southworth, J. & Dransfield, M. T., Sept 2020, In: Contemporary Clinical Trials Communications. 19, 100589.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Citations (Scopus)

First-In-Human Phase 1 Clinical Trials – A Single-Center Experience In The Era Of Modern Oncotherapeutics

Paluri, R. K., Li, P., Anderson, A., Nandagopal, L., McArdle, T., Young, M., Robert, F., Naik, G. & Saleh, M., 1 Dec 2020, In: Scientific Reports. 10, 1, 7935.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Citations (Scopus)

Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic Findings

Saleh, M., Cassier, P. A., Eberst, L., Naik, G., Morris, V. K., Pant, S., Terret, C., Gao, L., Long, A., Mao, H., McNeely, S., Wagner, E. K., Carlesi, R. M. & Fu, S., 1 Nov 2020, In: Oncologist. 25, 11, p. e1628-e1639

Research output: Contribution to journal › Article › peer-review

Open Access

4 Citations (Scopus)

TBCRC 002: A phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Vaklavas, C., Roberts, B. S., Varley, K. E., Lin, N. U., Liu, M. C., Rugo, H. S., Puhalla, S., Nanda, R., Storniolo, A. M., Carey, L. A., Saleh, M. N., Li, Y., Delossantos, J. F., Grizzle, W. E., Lobuglio, A. F., Myers, R. M. & Forero-Torres, A., 18 Feb 2020, In: Breast Cancer Research. 22, 1, 22.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Citations (Scopus)

2019

Breast Cancer knowledge, perceptions and practices in a rural Community in Coastal Kenya

Sayed, S., Ngugi, A. K., Mahoney, M. R., Kurji, J., Talib, Z. M., MacFarlane, S. B., Wynn, T. A., Saleh, M., Lakhani, A., Nderitu, E., Agoi, F., Premji, Z., Zujewski, J. A. & Moloo, Z., 12 Feb 2019, In: BMC Public Health. 19, 1, 180.

Research output: Contribution to journal › Article › peer-review

Open Access

25 Citations (Scopus)

Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study

Khelif, A., Saleh, M. N., Salama, A., Portella, M. D. S. O., Duh, M. S., Ivanova, J., Grotzinger, K., Roy, A. N. & Bussel, J. B., Feb 2019, In: American Journal of Hematology. 94, 2, p. 200-208 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

23 Citations (Scopus)

Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors

Paluri, R., Madan, A., Li, P., Jones, B., Saleh, M., Jerome, M., Miley, D., Keef, J. & Robert, F., 5 Mar 2019, In: Cancer Chemotherapy and Pharmacology. 83, 3, p. 551-559 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Citations (Scopus)

2018

Ethnicity and breast cancer characteristics in Kenya

Sayed, S., Moloo, Z., Wasike, R., Bird, P., Oigara, R., Njoroge, F. W., Shaikh, A. J., Prasad, S. V., Vinayak, S., Gierach, G. L., Dawsey, S. M., Palakal, M., Fan, S., Mullooly, M., Chauhan, R., Okiro, P., Gakinya, S., Nzioka, A., Kyobutungi, C., Mohamed, S., & 17 othersHaregu, T., Mussajee, M., Bonass, B., Mariwa, C., Sherman, O. A., Mohammed, A., Gachii, A., Githaiga, J., Karanu, J., Nyagah, R., Njoroge, R., Muramba, I., Otieno, J. O., Raburu, D. O., Mwachiro, E. B., Abayo, I. & Saleh, M., 1 Jan 2018, In: Breast Cancer Research and Treatment. 167, 2, p. 425-437 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Citations (Scopus)

Nano and microbubble systems for on-demand cancer drug delivery

Budhwani, K. I., Dettmann, M. A., Saleh, M. N. & Thomas, V., 1 Jan 2018, In: Current Nanoscience. 14, 1, p. 33-41 9 p.

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Promoting clinical breast evaluations in a lower middle-income country setting: An approach toward achieving a sustainable breast health program

Buribekova, R., Shukurbekova, I., Ilnazarova, S., Jamshevov, N., Sadonshoeva, G., Sayani, S., Aminmuhammad, A., Amersi, F., Asaria, S., Talib, Z. & Saleh, M., 1 Mar 2018, In: Journal of global oncology. 2018, 4, p. 1-8 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Citations (Scopus)

So You want to be a principal investigator

Saleh, M. & Naik, G., 1 Jun 2018, In: Journal of Oncology Practice. 14, 6, p. e384-e392

Research output: Contribution to journal › Article › peer-review

Open Access

6 Citations (Scopus)

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Ng, S. Y., Yoshida, N., Christie, A. L., Ghandi, M., Dharia, N. V., Dempster, J., Murakami, M., Shigemori, K., Morrow, S. N., Van Scoyk, A., Cordero, N. A., Stevenson, K. E., Puligandla, M., Haas, B., Lo, C., Meyers, R., Gao, G., Cherniack, A., Louissaint, A., Nardi, V., & 27 othersThorner, A. R., Long, H., Qiu, X., Morgan, E. A., Dorfman, D. M., Fiore, D., Jang, J., Epstein, A. L., Dogan, A., Zhang, Y., Horwitz, S. M., Jacobsen, E. D., Santiago, S., Ren, J. G., Guerlavais, V., Annis, D. A., Aivado, M., Saleh, M. N., Mehta, A., Tsherniak, A., Root, D., Vazquez, F., Hahn, W. C., Inghirami, G., Aster, J. C., Weinstock, D. M. & Koch, R., 1 Dec 2018, In: Nature Communications. 9, 1, 2024.

Research output: Contribution to journal › Article › peer-review

Open Access

76 Citations (Scopus)

2017

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

Rathkopf, D. E., Smith, M. R., Ryan, C. J., Berry, W. R., Shore, N. D., Liu, G., Higano, C. S., Alumkal, J. J., Hauke, R., Tutrone, R. F., Saleh, M., Maneval, E. C., Thomas, S., Ricci, D. S., Yu, M. K., de Boer, C. J., Trinh, A., Kheoh, T., Bandekar, R., Scher, H. I., & 1 othersAntonarakis, E. S., Sept 2017, In: Annals of Oncology. 28, 9, p. 2264-2271 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

73 Citations (Scopus)

Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone

Rathkopf, D. E., Antonarakis, E. S., Shore, N. D., Tutrone, R. F., Alumkal, J. J., Ryan, C. J., Saleh, M., Hauke, R. J., Bandekar, R., Maneval, E. C., De Boer, C. J., Yu, M. K. & Scher, H. I., 15 Jul 2017, In: Clinical Cancer Research. 23, 14, p. 3544-3551 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

77 Citations (Scopus)

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: Final results of the EXTEND study

Wong, R. S. M., Saleh, M. N., Khelif, A., Salama, A., Portella, M. S. O., Burgess, P. & Bussel, J. B., 7 Dec 2017, In: Blood. 130, 23, p. 2527-2536 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

228 Citations (Scopus)

2016

A community-oriented approach to breast cancer in a low-resource setting: Improving awareness, early detection and treatment of breast cancer in Tajikistan

Talib, Z., Shukurbekova, I., Sadonshoeva, G., Alibekov, A., Jamshedov, N., Moloo, Z., Welji, A., Amersi, F., Muhammad, A. A., Jiwani, A., Rais, S., Nazrishoeva, A., Ilnazarova, S., Nuridinova, S., Ukani, H., Alwani, S. & Saleh, M., 1 May 2016, In: Breast Journal. 22, 3, p. 330-334 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Citations (Scopus)

Breast camps for awareness and early diagnosis of breast cancer in countries with limited resources: A multidisciplinary model from Kenya

Sayed, S., Moloo, Z., Ngugi, A., Allidina, A., Ndumia, R., Mutuiri, A., Wasike, R., Wahome, C., Abdihakin, M., Kasmani, R., Spears, C. D., Oigara, R., Mwachiro, E. B., Busarla, S. V. P., Kibor, K., Ahmed, A., Wawire, J., Sherman, O., Saleh, M., Zujewski, J. A., & 1 othersDawsey, S. M., Sept 2016, In: Oncologist. 21, 9, p. 1138-1148 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

24 Citations (Scopus)

Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia

Liebman, H. A., Saleh, M. N., Bussel, J. B., George Negrea, O., Horne, H., Wegener, W. A. & Goldenberg, D. M., 31 Oct 2016, In: Haematologica. 101, 11, p. 1327-1332 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Citations (Scopus)

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

Mackey, J. R., Pieńkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M. F., Sauter, G., Lindsay, M., Houé, V., Buyse, M., Drevot, P., Hitier, S., Bensfia, S. & Eiermann, W., 18 Jun 2016, In: Annals of Oncology. 27, 6, p. 1041-1047 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

46 Citations (Scopus)

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients

Madan, A., Jones, B. S., Bordoni, R., Saleh, M. N., Jerome, M. S., Miley, D. K., Jackson, B. E. & Robert, F., 1 Sept 2016, In: Cancer Chemotherapy and Pharmacology. 78, 3, p. 509-515 7 p.

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

2015

EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer

Yardley, D. A., Weaver, R., Melisko, M. E., Saleh, M. N., Arena, F. P., Forero, A., Cigler, T., Stopeck, A., Citrin, D., Oliff, I., Bechhold, R., Loutfi, R., Garcia, A. A., Cruickshank, S., Crowley, E., Green, J., Hawthorne, T., Yellin, M. J., Davis, T. A. & Vahdat, L. T., 10 May 2015, In: Journal of Clinical Oncology. 33, 14, p. 1609-1619 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

156 Citations (Scopus)

Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC)

Allendorf, D. J., Bordoni, R. E., Grant, S. C., Saleh, M. N., Reddy, V. B., Jerome, M. L., Dixon, P. M., Miley, D. K., Singh, K. P. & Robert, F., 1 Nov 2015, In: Cancer Chemotherapy and Pharmacology. 76, 5, p. 949-955 7 p.

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

SPIRITT: A randomized, multicenter, phase II study of panitumumab with FOLFIRI and bevacizumab with FOLFIRI as second-line treatment in patients with unresectable wild type KRAS metastatic colorectal cancer

Hecht, J. R., Cohn, A., Dakhil, S., Saleh, M., Piperdi, B., Cline-Burkhardt, M., Tian, Y. & Go, W. Y., 1 Jun 2015, In: Clinical Colorectal Cancer. 14, 2, p. 72-80 9 p.

Research output: Contribution to journal › Article › peer-review

97 Citations (Scopus)

2014

A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors

Pant, S., Saleh, M., Bendell, J., Infante, J. R., Jones, S., Kurkjian, C. D., Moore, K. M., Kazakin, J., Abbadessa, G., Wang, Y., Chen, Y., Schwartz, B. & Camacho, L. H., Jul 2014, In: Annals of Oncology. 25, 7, p. 1416-1421 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

72 Citations (Scopus)

A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer

Galsky, M. D., Vogelzang, N. J., Conkling, P., Polzer, J., Roberson, S., Stille, J. R., Saleh, M. & Thornton, D., 1 Jul 2014, In: Clinical Cancer Research. 20, 13, p. 3581-3588 8 p.

Research output: Contribution to journal › Article › peer-review

95 Citations (Scopus)

A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Lin, E. H., Lenz, H. J., Saleh, M. N., Mackenzie, M. J., Knost, J. A., Pathiraja, K., Langdon, R. B., Yao, S. L. & Lu, B. D., Aug 2014, In: Cancer Medicine. 3, 4, p. 988-997 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Citations (Scopus)

Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting

Saleh, M. N., Haislip, S., Sharpe, J., Hess, T., Gilmore, J., Jackson, J., Sail, K. R., Ericson, S. G. & Chen, L., Apr 2014, In: Current Medical Research and Opinion. 30, 4, p. 529-536 8 p.

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya

Sayed, S., Moloo, Z., Wasike, R., Bird, P., Oigara, R., Govender, D., Kibera, J., Carrara, H. & Saleh, M., 1 Oct 2014, In: Breast. 23, 5, p. 591-596 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

49 Citations (Scopus)

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer

Bendell, J., Saleh, M., Rose, A. A. N., Siegel, P. M., Hart, L., Sirpal, S., Jones, S., Green, J., Crowley, E., Simantov, R., Keler, T., Davis, T. & Vahdat, L., 10 Nov 2014, In: Journal of Clinical Oncology. 32, 32, p. 3619-3625 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

94 Citations (Scopus)

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer

O'Shaughnessy, J., Hellerstedt, B., Schwartzberg, L., Yardley, D. A., Danso, M. A., Robert, N., Richards, P., Miller, K. D., Rugo, H. S., Carlson, R. W., Finn, R. S., Neubauer, M., Saleh, M., Specht, J. M., Charpentier, E., Garcia-Ribas, I. & Winer, E. P., 1 Dec 2014, In: Journal of Clinical Oncology. 32, 34, p. 3840-3847 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

264 Citations (Scopus)

Severe neutropenia and relative dose intensity among patients <65 and ≥65 years with non-Hodgkin's lymphoma receiving CHOP-based chemotherapy

Schwartzberg, L. S., Saleh, M., Whittaker, S. & Abella, E., Jul 2014, In: Supportive Care in Cancer. 22, 7, p. 1833-1841 9 p.

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

2013

Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: The Kenyan experience

Sayed, S., Moloo, Z., Bird, P., Wasike, R., Njoroge, W., Karanu, J., Nzioka, A., Sherman, O., Prasad, S., Mariwa, C., Otieno, J. O., Chumba, D., Koech, D., Mbinga, D., Mohammed, M., Njoroge, R., Chauhan, R., Vinayak, S., Kyobutungi, C. & Saleh, M., Apr 2013, In: Journal of Clinical Pathology. 66, 4, p. 307-311 5 p.

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., Harris, M., Reni, M., Dowden, S., Laheru, D., Bahary, N., Ramanathan, R. K., Tabernero, J., Hidalgo, M., Goldstein, D., Van Cutsem, E., & 3 othersWei, X., Iglesias, J. & Renschler, M. F., 2013, In: New England Journal of Medicine. 369, 18, p. 1691-1703 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

5052 Citations (Scopus)

Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: A phase I study

Liebman, H. A., Saleh, M. N., Bussel, J. B., Negrea, O. G., Horne, H., Wegener, W. A. & Goldenberg, D. M., Sept 2013, In: British Journal of Haematology. 162, 5, p. 693-701 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

27 Citations (Scopus)

Mansoor Saleh

Research output

Search results